New mRNA vaccine could reduce the recurrence and spread of skin cancer

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research. Source: Read the original article on www.npr.org